The O-glycan is essential for the induction of protective antibodies against lethal infection by flagella A-bearing Pseudomonas aeruginosa
To address the problem of increased antimicrobial resistance, we developed a glycoconjugate vaccine comprised of O-polysaccharides (OPS) of the four most prevalent serotypes of Klebsiella pneumoniae (KP) linked to recombinant flagellin types A and B (rFlaA and rFlaB) of Pseudomonas aeruginosa (PA). Flagellin is the major subunit of the flagellar filament. Flagella A and B, essential virulence factors for PA, are glycosylated with different glycans. We previously reported that while both rFlaA and rFlaB were highly immunogenic, only the rFlaB antisera reduced PA motility and protected mice from lethal PA infection in a mouse model of thermal injury. Since recombinant flagellin is not glycosylated, we examined the possibility that the glycan on native FlaA (nFlaA) might be critical to functional immune responses. We compared the ability of nFlaA to that of native, deglycosylated FlaA (dnFlaA) to induce functionally active antisera. O glycan was removed from nFlaA with trifluoromethanesulfonic acid. Despite the similar high-titered anti-FlaA antibody levels elicited by nFlaA, rFlaA, and dnFlaA, only the nFlaA antisera inhibited PA motility and protected mice following lethal intraperitoneal bacterial challenge. Both the protective efficacy and carrier protein function of nFlaA were retained when conjugated to KP O1 OPS. We conclude that unlike the case with FlaB O glycan, the FlaA glycan is an important epitope for the induction of functionally active anti-FlaA antibodies.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:92 |
---|---|
Enthalten in: |
Infection and immunity - 92(2024), 3 vom: 12. März, Seite e0042723 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Choi, Myeongjin [VerfasserIn] |
---|
Links: |
---|
Themen: |
12777-81-0 |
---|
Anmerkungen: |
Date Completed 13.03.2024 Date Revised 14.03.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1128/iai.00427-23 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368811905 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368811905 | ||
003 | DE-627 | ||
005 | 20240314235220.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240229s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1128/iai.00427-23 |2 doi | |
028 | 5 | 2 | |a pubmed24n1329.xml |
035 | |a (DE-627)NLM368811905 | ||
035 | |a (NLM)38391207 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Choi, Myeongjin |e verfasserin |4 aut | |
245 | 1 | 4 | |a The O-glycan is essential for the induction of protective antibodies against lethal infection by flagella A-bearing Pseudomonas aeruginosa |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 13.03.2024 | ||
500 | |a Date Revised 14.03.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a To address the problem of increased antimicrobial resistance, we developed a glycoconjugate vaccine comprised of O-polysaccharides (OPS) of the four most prevalent serotypes of Klebsiella pneumoniae (KP) linked to recombinant flagellin types A and B (rFlaA and rFlaB) of Pseudomonas aeruginosa (PA). Flagellin is the major subunit of the flagellar filament. Flagella A and B, essential virulence factors for PA, are glycosylated with different glycans. We previously reported that while both rFlaA and rFlaB were highly immunogenic, only the rFlaB antisera reduced PA motility and protected mice from lethal PA infection in a mouse model of thermal injury. Since recombinant flagellin is not glycosylated, we examined the possibility that the glycan on native FlaA (nFlaA) might be critical to functional immune responses. We compared the ability of nFlaA to that of native, deglycosylated FlaA (dnFlaA) to induce functionally active antisera. O glycan was removed from nFlaA with trifluoromethanesulfonic acid. Despite the similar high-titered anti-FlaA antibody levels elicited by nFlaA, rFlaA, and dnFlaA, only the nFlaA antisera inhibited PA motility and protected mice following lethal intraperitoneal bacterial challenge. Both the protective efficacy and carrier protein function of nFlaA were retained when conjugated to KP O1 OPS. We conclude that unlike the case with FlaB O glycan, the FlaA glycan is an important epitope for the induction of functionally active anti-FlaA antibodies | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Klebsiella pneumoniae | |
650 | 4 | |a O polysaccharide | |
650 | 4 | |a O-glycan | |
650 | 4 | |a Pseudomonas aeruginosa | |
650 | 4 | |a conjugate vaccine | |
650 | 4 | |a flagellin | |
650 | 7 | |a Flagellin |2 NLM | |
650 | 7 | |a 12777-81-0 |2 NLM | |
650 | 7 | |a Antibodies |2 NLM | |
650 | 7 | |a Polysaccharides |2 NLM | |
650 | 7 | |a Immune Sera |2 NLM | |
700 | 1 | |a Shridhar, Surekha |e verfasserin |4 aut | |
700 | 1 | |a Fox, Heather |e verfasserin |4 aut | |
700 | 1 | |a Luo, Kun |e verfasserin |4 aut | |
700 | 1 | |a Amin, Mohammed N |e verfasserin |4 aut | |
700 | 1 | |a Tennant, Sharon M |e verfasserin |4 aut | |
700 | 1 | |a Simon, Raphael |e verfasserin |4 aut | |
700 | 1 | |a Cross, Alan S |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Infection and immunity |d 1970 |g 92(2024), 3 vom: 12. März, Seite e0042723 |w (DE-627)NLM000004278 |x 1098-5522 |7 nnns |
773 | 1 | 8 | |g volume:92 |g year:2024 |g number:3 |g day:12 |g month:03 |g pages:e0042723 |
856 | 4 | 0 | |u http://dx.doi.org/10.1128/iai.00427-23 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 92 |j 2024 |e 3 |b 12 |c 03 |h e0042723 |